chrisvoncsefalvay/vaers-outcomes huggingface dataset:
So I had some on and off chest pain for the week after I got the vaccine, I didn't think it was because of the vaccine initially. It started to get consistent and then 2 weeks after the vaccine it became very intense pain to where I could not carry anything or sit or stand comfortably. About three weeks after my vaccine I was able to get in with a PCD and she did not attribute it to the vaccine, she put me on 600MG of Motrin every 8 hours and that managed the pain pretty well. She wanted me to take the meds for a week but the pain continued so I am now still taking the medicine. I saw my own PCD a week later and she ran a lot of tests, still no definitive answers.
Patient states her vaccinated arm has been sore "off and on" since receiving two doses of Moderna COVID-19 vaccine. She said "the muscle in that spot is killing me", and she reports some limited mobility.  She followed up with her PCP and plans to follow up again per PCP recommendation since she is still in pain. She said she has applied cold and heat to the site, as well as taking tylenol with no relief. Additionally, she reports experiencing a rash after each dose of vaccine. The rash started the day after vaccination and lasted about 1 to 1 & 1/2 weeks.
Gave .5cc of H1N1 instead of .25cc. No adverse problems from dose Sanofi Pasteur stated MD harm to child. Give .25cc booster dose in one month.
"hives" all over; some swelling noted to hives; no difficulty breathing (no cough, wheeze, shortness of breath, drooling, gagging, tongue swelling, or color changes noted); pt was crying hard in the background of the phone call. As long as no difficulty breathing, RN advised Benadryl 12.5 mg/5 mL, 5 mL po based on pt 33 pounds wt in office that day.  One hour later pt was in ER with hives from head to hips (not on legs where vaccines were given); Benadryl had been taken and Pepcid (no epinephrine or oxygen needed). Pt was assessed and monitored at ER for about 3 hours.
nonproductive cough, chills resolved, fatigue, post nasal drainage, sneezing starting 1/1/22
Case number PHEH2014US003839 is an initial spontaneous report received from a consumer (patient's parent) on 24 FEB 2014: This report refers to a 16-year-old male patient who was inadvertently vaccinated with FLUCELVAX (batch number: unknown) intramuscularly on an undetermined date in DEC 2013. No adverse event was reported following this administration error (inappropriate age at vaccine administration).  Following an internal review on 18 AUG 2014 of the data received on 24 FEB 2014, it was identified that the BPI labeling of the event "inappropriate age at vaccine administration" was erroneously captured as listed and hence the labeling was now changed as unlisted and second indication off-label use was added to the case.
Patient developed redness & swelling at injection site- 6.5 X 10 cm.
Headache, chills, fever for 2 days, Nausea and unable to burp or pass gas, lingering for 4 weeks (still at this time) constipation. Fatigue, stomach ache, pain at injection site (went away in 5 days). Feeling of being "unwell". Still having episodes of fatigue, stomach ache & nausea despite following a limited diet (mostly liquids and soda to encourage burping.
This spontaneous report was received from a medical assistant and refers to an unspecified patients of unknown age and gender. On 24-AUG-2017, the unspecified number of improperly stored doses of VARIVAX lot # N008077, expiration date 09-MAR-2019 (dose, route and anatomical location were not reported) were administered to the patients. The doses were stored in temperatures from 15 degrees Fahrenheit to 46 degrees Fahrenheit for 15 hours 38 minutes. Data logger was involved. There was no previous excursion reported. No adverse effects have been reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA011737.
One week after I received the vaccination the area on the right arm where the shot was given had a rash. It it was a little itchy in the afternoon. In the evening when I looked at it the rash was there.  I called the school nurse to report it and was told to take Benadryl  and report the symptom to VAERS. and it will resolve.
COVID -19 Treatment; COVID -19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Nov2021 at 12:00 as dose 3 (booster), single (Lot number: ff2593) at the age of 63 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa medication" (unspecified if ongoing), notes: Known allergies: Sulfa medication. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "not recovered" and all described as "COVID -19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Positive covid test with full covid symptoms returning. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Anti viral start date: 15Jul2022 and Treatment stop date: 19Jul2022  No follow-up attempts are possible. No further information is expected.
Patient got dizzy immediately and wanted to sit down, he also stated he was short of breath. His blood pressure was 160/111 and pulse 107.  Rechecked shortly after that blood pressure check and it went to 176/115 and pulse 138. Patient stated he was feeling well and requested to go to ED, staff called 911.
My arm was very sore to the touch and hurt to move. I developed symtoms like a bad flu withou chest and nasal symptoms. I had a bad headache. Severe fatigue and body aches. Ran a temp of 99.1 for about 12 hours. Took no reducers.  From the night of the shot to mid-day (48 hours later) I slept 30 hours. I woke up to use the restroom. I drank a lot of water. After 48  hours and all that sleep and water, I felt better. A little fatigue for a couple of days more.
Tinnitus in left ear. Pulsing ringing. Sensation of ear being clogged. Guessing about 70% reduction in hearing on that side. The vaccine was the Spikevax version of the Moderna vaccine.
Information has been received from a medical assistant concerning a patient of unknown age and gender. There was no information about patient's concurrent conditions, medical history or concomitant medications. On 12-FEB-2018, the patient was inadvertently vaccinated with an expired dose of PROQUAD lot # M035689 and expiration date of 06-FEB-2018, (route of administration and anatomical location were not reported) for prophylaxis. Vaccine was reconstituted with sterile diluent(MERCK STERILE DILUENT) lot # L034400 and expiration date of 17-APR-2018.
I was getting an MRI and I began to itch horribly, and I ended up being taken to ER.
16 YEAR OLD PRESENTED FOR BOOSTER  VACCINE AND FLU VACCINES, RECEIVED BOTH
Patient was expecting to receive COVID19 PFIZER UPDATED BOOSTER 12+, instead received COVID19 (PFIZER AGE 12+) GRAY CAP
Warm to touch; Red area at site of injection; This spontaneous case was reported by a pharmacist and describes the occurrence of FEELING HOT (Warm to touch) and VACCINATION SITE ERYTHEMA (Red area at site of injection) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 031M20A) for COVID-19 vaccination.     No medical history report provided by the reporter.  Concomitant products included LISINOPRIL, ATORVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Warm to touch) and VACCINATION SITE ERYTHEMA (Red area at site of injection). At the time of the report, FEELING HOT (Warm to touch) and VACCINATION SITE ERYTHEMA (Red area at site of injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was given Advil on 17 Mar 2021 to treat AE.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14 july 2021 and it contains no new information.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 15-DEC-2015 at 11:40, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. The high and low temperatures were 7.9 and 4.6 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
hives and itchiness from scalp to foot; hives and itchiness from scalp to foot; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced hives and itchiness from scalp to foot on 09Apr2021 with outcome of unknown. The patient got the Pfizer shot on 08Apr2021 and breaking out in full body hives, it was the first shot of Pfizer Covid 19 vaccine. The patient would like to know what she was supposed to do, she had full body hives everywhere from head all the way down to her feet. Reporter seriousness for the events: Unspecified.   No follow-up attempts are needed. No further information is expected. Information about lot/batch number cannot be obtained.
Child was given MMR and Varivax vaccines on 03/29/05. 12 days after immunizations was given, the child broke out in a rash. Pt was diagnosed with measles rash from vaccine. Given Benadryl for home.
This spontaneous report as received from a female patient of unknown age refers to herself. On an unknown date, the patient was vaccinated with ZOSTAVAX dose, lot number, expiration date not reported. On an unknown date, the patient experienced injection site reactions, including pain, itching, redness and swelling. The patient reported a headache a few times too (dates unspecified). On an unknown date, the patient recovered from all events. Relatedness between the events and ZOSTAVAX was not reported. Additional information is not expected, no contact details for physician and consumer were available.
Vertigo, Migraine, Myalgias and bedridden for 24 hrs began at time indicated above resulting in work loss and illness lasting for 3-5 days
So at 3hrs after second shot my arm hurt,   18hrs I felt really tired.  20hrs I was freezing.  24hrs chills and headache.
Atopic dermatitis; itching on skin face and neck; Erythema; Urticaria; Heart rate increased; Itching and redness in eyes; Feeling Hot; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ATOPIC (Atopic dermatitis), PRURITUS (itching on skin face and neck), ERYTHEMA (Erythema), URTICARIA (Urticaria) and HEART RATE INCREASED (Heart rate increased) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic interstitial cystitis, Irritable bowel syndrome, Sleep apnea, Prediabetes and Rhinitis. Concomitant products included BACLOFEN, CITALOPRAM HYDROBROMIDE (CITALOPRAM [CITALOPRAM HYDROBROMIDE]), METFORMIN and PENTOSAN POLYSULFATE SODIUM (ELMIRON) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DERMATITIS ATOPIC (Atopic dermatitis), PRURITUS (itching on skin face and neck), ERYTHEMA (Erythema), URTICARIA (Urticaria), HEART RATE INCREASED (Heart rate increased), EYE PRURITUS (Itching and redness in eyes) and FEELING HOT (Feeling Hot). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) ongoing since an unknown date at a dose of 2- 3 tabs a day; CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of 4 shots and TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE (GLUCOCORTICOID)) at an unspecified dose and frequency. At the time of the report, DERMATITIS ATOPIC (Atopic dermatitis), PRURITUS (itching on skin face and neck), ERYTHEMA (Erythema), URTICARIA (Urticaria), HEART RATE INCREASED (Heart rate increased), EYE PRURITUS (Itching and redness in eyes) and FEELING HOT (Feeling Hot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, Blood pressure measurement: 160/94 mmHg (High) 160/94. On 27-Jan-2021, Body temperature: 97.7 (normal) 97.7. On 27-Jan-2021, Heart rate: 91 (normal) 91. On 27-Jan-2021, Respiratory rate: 98 (abnormal) 98. On 17-Jun-2021, Biopsy: Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-133981.
pt recvd Hep B vax on 27FEB92 & that evening exp throbbing discomfort @ inject site w/malaise & drowsiness; 28FEB92 exp a h/a, nasal congestion, stiff neck, discomfort under rt scapula, malaise, achiness;
Patient with syncope a few minutes after vaccination. Able to keep patient upright in chair until able to get in wheelchair. After a minute or two, patient was alert again. Given juice. Vitals stable. Able to discharge home with boyfriend.
scratchy throat, hoarse voice, itchy ears inside.  1 1/2 hrs after vaccine. 12/23/20
Initially itching, painful burning hives and welts on both arms began about Jan 12-13.     Began low dose benedryl from 1/13 - 1/25.    Second adverse event on Jan 25; began sudden onset of dizziness, weakness, nausea, vomiting and unusual blood pressure elevation.   Went to ER @4 pm..   Released after 6 hours.   Same occurrence next day, similar symptoms.   Began to feel 'bad';   BP still elevated.  Went to closest ER at 3 pm.     Discharged after 5 hours with clonidine.    Skipped a day, but could not resume normal activities.   On Jan 29 returned to ER early afternoon, admitted for observation.   Discharged ~6:30 pm on Jan 30.   Currently only on higher dose of losinipryl.    Rash bumps persist as 'red streaks', elevated BP and not feeling well.   Streak is inner right arm above elbow.    Rash streaks continue but are not bother some.   Including morning of 1:30 after night in hospital.  Rash usually appears  after sleeping and early a.m.   No medication.   Still unable to resume normal activities.  "feel terrible".
Patient given Moderna shot as second dose on 5/21/2021 after receiving Pfizer shot as first dose on 4/23/2021.
This spontaneous report was received from a physician referring two patients of unknown gender "in their twenties". Pertinent medical history and drug reactions/allergies were not reported. On an unknown date the patients were vaccinated with RECOMBIVAX HB (Lot #, dose and route not reported). No concomitant therapies were reported. It was reported that the patients needed to be "revaccinated" with RECOMBIVAX HB after "losing immunity" (onset date not reported). It was unable to be confirmed whether either patient previously received any doses of RECOMBIVAX HB but it could not be ruled out. At the time of the report the patients outcome were unknown. Additional information has been requested (correspondence containing a request for additional information is scheduled).
1 week later after injection..... very tired, swollen, hot, and red at the injection site.  brain fog, can?t concentrate. Chills and feel sick but no fever.
This spontaneous report as received from a physician via company representative refers to a female patient of unknown age. The patient's medical history, drug reactions and allergies and concomitant medication were not reported. On an unknown date, the patient was vaccinated with the second dose of GARDASIL, therapy route, dose, lot#, batch# and expiry date were not reported. On an unknown date, after the vaccination, the patient experienced abdominal pain and nausea. On an unspecified date, the patient had a gastrointestinal examination (reported as "gastrointestinal work up"), the results were not reported. The outcome of abdominal pain and nausea was unknown. The relatedness between vaccination with GARDASIL and the events was not reported. Additional information has been requested.
Vaccinated 8/28/09 about 4 p.m.  First hematuria observed on Sunday, 3/30/09 at home in late morning urination. BP+ 120/80  Afternoon, hematuria with small red blood clot. BP without BP medicine at 8:15 138/78. Patient receives Coumadin 2.5 per day.  Took one extra Coumadin yesterday afternoon because blood clotting time was 1.6, which is below target of 2.5 to 3.5.  Patient attributes the fast clotting time to eating too much mayonnaise, and possible increase in E. coli production of Vitamin K, due to recent diarrhea.  Patient, a former  Hospital associate, observed the urine color was classical for positive for hepatitis, with some what added redness at end of cycle of urination (probably RBCs not clotted).  There is a history of probable Schistomiasis by S. Haema..., which patient found in urine about 2 months ago (live and moving female Schistomiasis sp.) along with 2 "rafts" of shimmering capillary-appearing mats about 0.5 cm each.  Unusually, patient one month later, passed a female and male Schistosome sp. at end of very constipated and dry feces bowel movement (Patient felt something on rectal area, and, using a toilet paper, recovered another female Schistosome) (apparently dead) along with what patient later discovered was the male Schistome sp.  Each were about 2 cm or less.  Unusual, in that Schistomiasis sp. (japonicus or mansoni) worms are normally found on the exterior of the lumen. At the time, patient had been taking medicine firstly for roundworms, and secondly, for pinworms, respectively. Patient has history of visiting a foreign country, with probable contact in a fish pond in a foreign country.  Also visited other countries, and has had relations with a female from a foreign area area, who was discovered to be positive for roundworms (cause for first medication regime--Mebendazole).
Within 24 hours the left arm swelled up. About 10 times the size of his arm. An intense cough started on the second day after the injection and lasted for 3 weeks. Poor sleeping started almost immediately as well as changes in appetite. Diarrhea started one week post vaccination and lasted for 8 weeks. Bowels are still not what they used to be. Still loose and urgency is increased. Behavioral changes occurred a couple of weeks after the vaccination and are still continuing.
Chills began at 9 pm the day of vaccination, fever of 100.1 followed by midnight and continued to worsen even after taking Extra Strength Tylenol. Body aches, slight nausea, low grade headache followed. I felt better by 7 am but then chills and fever came on again around 11 am (up to 101.2) and lasted through the present time, about 9 pm. I'd exhausted the standard dose of acetaminophen so followed up with a telemedicine visit and the doctor suggested I alternate ibuprofen with acetaminophen. Fever seems to have broken now.
Sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), BUPROPION HYDROCHLORIDE (WELLBUTRIN), METFORMIN, MONTELUKAST SODIUM (SINGULAIR) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection). At the time of the report, SINUSITIS (Sinus infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included antibiotics for sinus infection.
Erythema, swelling and tenderness at injection site extending distally to forearm (left) extent 25cmx12cm.
pt reports fever, GI upset, hives, eye swollen, chills, angeo edema
I can no longer walk without crutches, I can no longer work my flight attendant job; Five days after the second dose I lost the ability to walk unassisted....... I can no longer walk without crutches; I constantly live in excruciating pain 24/7; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (Pfizer-BioNTech COVID-19), in Sep2021 as dose 2, single (Lot number: FE3592) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Lot Number: FA7484), administration date: Aug2021, for COVID-19 Immunization. Prior to the vaccine, patient was a healthy long distance runner, hiker, and flight attendant for 32 years. The following information was reported: LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (disability), outcome "not recovered", described as "I can no longer walk without crutches, I can no longer work my flight attendant job"; GAIT DISTURBANCE (disability), outcome "not recovered", described as "Five days after the second dose I lost the ability to walk unassisted....... I can no longer walk without crutches"; PAIN (medically significant), outcome "not recovered", described as "I constantly live in excruciating pain 24/7". Clinical course:  Patient received the mandatory Pfizer Covid Vaccine in Aug2021 and the second dose Sep2021. Five days after the second dose I (patient) lost the ability to walk unassisted.  I can no longer work my flight attendant job and I constantly live in excruciating pain 24/7.
Nine days post vax the pt experienced a febrile seizure and was hospitalized as a result. The pt also developed a varicella rash that consisted of 10 -121 lesions. The pt had a fever of 105F. The reporting physician felt that the febrile seizure and the varicella rash may have been related to varicella virus vaccine live.
On 30 Apr 21 nineteen Pfizer COVID-19 vaccinations were administered to patients after the 6-hr beyond use time required by the manufacturer.
A week after vaccination, I woke with a rash that was itchy, hot and swollen at the injection site. I ended up going to urgent care as advised by my doctor. They are treating it as a puncture wound with steroid and antibiotics, which I have yet to finish and see complete resolution of the reaction.
No adverse events. Patient was given pediatric Hepatitis A instead of receiving adult Hepatitis A vaccination. Patient has been informed and has been instructed to come back for his full dose of Hepatitis A.